How to Get a GLP-1 Prescription Online: Step-by-Step

Getting a GLP-1 prescription online is not as simple as filling out a form and receiving medication. It requires a real clinical evaluation by a licensed provider who reviews your complete health history and determines whether the medication is medically appropriate for you.

This page explains exactly how that evaluation works, what to expect at each step, and how we keep the process streamlined and confidential.

Why the Evaluation Matters

GLP-1 medications like semaglutide and tirzepatide are powerful tools that work on your appetite, digestion, and glucose regulation. They’re not appropriate for everyone. Your provider needs to know your full health history, current medications, and any contraindications before prescribing.

The evaluation is not a barrier. It’s a safeguard. It ensures that if you receive a prescription, it’s because a licensed medical provider believes the medication will help you and poses an acceptable risk profile for your specific situation.

How Many People Actually Qualify?

BMI eligibility is the first criterion. According to the National Institutes of Health (NIH), GLP-1 medications are indicated for adults with ^[1]:

• A BMI of 27 or higher with at least one weight-related health condition (such as high blood pressure, prediabetes, or heart disease), or
• A BMI of 30 or higher regardless of other conditions

However, BMI alone doesn’t determine eligibility. Your provider will also evaluate your medical history, medications, and any conditions that might make GLP-1 medication inappropriate.

The CDC reports that roughly 42% of U.S. adults live with obesity (BMI 30+) ^[3], but not all of those individuals will qualify for or benefit from GLP-1 medication. Your provider makes that determination on a case-by-case basis.

The 3-Step Process

Step 1: Complete Your Health Assessment (5 Minutes)

The assessment is a confidential questionnaire that gives your provider the information needed to make a clinical decision. It covers:

Your health profile:

• Age, height, weight, and BMI (we calculate this for you)
• Current medical conditions (thyroid disease, diabetes, heart disease, cancer history, pancreatitis, etc.)
• Family medical history
• Any previous weight loss attempts and what happened

Your medications:

• All prescription medications, including doses
• Over-the-counter medications and supplements
• Any allergies or adverse drug reactions

Your goals and preferences:

• What weight loss goal would be realistic for you
• Your preferred medication form (injectable or oral)
• Any specific health concerns or questions

What you’ll need to provide:

• A valid photo ID for identity verification
• A recent photo of yourself for your medical record
• Payment information (Visa, Mastercard, Apple Pay, Google Pay, or FSA/HSA card) if you qualify and choose to proceed

The assessment is completely free. There is no cost and no obligation. You only pay if your provider approves a prescription and you choose to move forward.

Step 2: Provider Clinical Review (24-48 Hours)

A board-certified, U.S.-licensed provider affiliated with OpenLoop Health reviews your complete assessment. This is a genuine clinical evaluation, not an automated approval process.

Your provider evaluates:

• BMI, age, and whether you meet eligibility criteria
• Your health history, focusing on any contraindications
• Your current medications and potential interactions with GLP-1
• Whether the medication is clinically appropriate for your specific situation
• Which medication option (if any) is the best fit
• What starting dose and monitoring schedule you’ll need

The provider’s possible decisions:

• Approve the prescription if GLP-1 is medically appropriate for you
• Decline the prescription if the medication is not appropriate for your health profile
• Request additional information if needed to make the decision

If the provider declines, you won’t be charged. The decision is purely medical, based on your health history and the provider’s clinical judgment.

If the provider approves a prescription, it is routed to one of our licensed, U.S.-based compounding pharmacies for preparation.

Step 3: Medication Prepared and Shipped (3-5 Business Days)

Once prescribed:

• Your prescription is sent to a licensed U.S.-based compounding pharmacy
• Your personalized dose is prepared according to the provider’s specifications
• The medication is quality-checked and packaged in discreet, temperature-controlled packaging
• It ships via 2-day priority mail with tracking
• Typical delivery time is 3-5 business days depending on your location
• Your care team sends you dosing instructions and how to administer the medication

From the moment your assessment is submitted to when medication arrives at your door typically takes 5-7 business days.

What the Provider Evaluates (The Clinical Side)

Understanding what your provider looks at helps explain why this is not a rubber-stamp process.

Eligibility criteria ^[1][2]: Your BMI must meet the threshold for GLP-1 medication. The standard is BMI 27 or higher with a weight-related condition, or BMI 30 or higher regardless of other conditions. The microdose program accepts BMI 20 or higher for maintenance and lower-dose protocols.

Contraindications: Your provider checks whether you have any conditions that make GLP-1 medication unsafe. These include a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, acute pancreatitis, or severe gallbladder disease. Having one of these conditions doesn’t automatically disqualify you, but it requires careful assessment.

Medication interactions: GLP-1 medications can affect how your body absorbs other drugs. Your provider reviews your current medications to identify any significant interactions. For example, if you take certain diabetes medications or blood pressure drugs, your provider may need to adjust those doses once you start GLP-1.

Overall health picture: Your provider considers your full situation. Someone with well-controlled diabetes may be a good candidate. Someone in active cancer treatment may not be. Someone with severe kidney disease may need monitoring. These are individual clinical decisions made by a licensed provider, not automated rules.

Psychological readiness: Your provider may also consider whether you have realistic expectations and whether you understand that GLP-1 is a tool, not a cure. The medication works best when you’re committed to lifestyle changes alongside it.

Differences Between Telehealth and In-Person Evaluation

Many people wonder if a telehealth evaluation is as thorough as an in-person visit. The answer is: for most patients, yes, because the evaluation is based on your health history and medical information, not on a physical exam.

Your provider doesn’t need to examine you in person to determine whether GLP-1 is appropriate. They need your accurate health history, your current medications, your BMI, and your goals. All of that is captured in the assessment.

If your provider determines that an in-person exam is necessary for your specific situation, they will let you know. Residents of Arkansas, DC, Delaware, Mississippi, New Mexico, Rhode Island, and West Virginia are required by state law to complete one live video consultation before a prescription can be written. That video consultation takes 10-15 minutes and is a one-time requirement.

Your Medication and the Pharmacy

What are compounded medications?

Compounded medications are prepared by state-licensed pharmacies according to a provider’s prescription. Your pharmacist compounds (mixes) the medication in the specific dose your provider ordered.

The active ingredients in our compounded products, semaglutide and tirzepatide, are the same compounds found in FDA-approved branded medications like Ozempic, Wegovy, Mounjaro, and Zepbound. However, compounded products are not FDA-approved. The FDA does not review or evaluate compounded medications for safety, efficacy, or quality.

This matters. It means ^[4]:

• Compounded products have not been evaluated by the FDA for purity or potency
• Formulation and stability may differ between compounding pharmacies
• Quality standards depend on the pharmacy’s expertise and state oversight
• You should discuss any concerns about compounded vs. branded products with your provider

Why choose compounded?

The main reason is cost. Compounded GLP-1 medications are significantly less expensive than branded products, making the medication accessible to more people. At Transformation Health, all-inclusive pricing for compounded semaglutide starts at $249 per month.

The tradeoff is accepting the regulatory status of a compounded product rather than an FDA-approved one. This is a legitimate medical decision you should discuss with your provider.

Our pharmacy partners:

We work exclusively with licensed, U.S.-based, state-regulated compounding pharmacies that specialize in metabolic medications. Your prescription is automatically routed to the partner with the best current availability, ensuring the fastest delivery to your location.

Who Is Responsible for What

This is important to understand:

Transformation Health (our role):

• Operates the assessment platform
• Helps you complete the health questionnaire
• Manages scheduling and communication
• Arranges delivery once a prescription is written
• Provides coaching, nutrition guidance, and patient support

Your provider (affiliated with OpenLoop Health):

• Reviews your assessment independently
• Makes all clinical decisions about whether medication is appropriate
• Writes the prescription if clinically indicated
• Determines the specific medication, dose, and monitoring plan
• Is legally and clinically responsible for the prescription

The compounding pharmacy:

• Receives the prescription
• Prepares your medication according to the provider’s specifications
• Ensures quality and sterility
• Packages and ships your medication

You are not purchasing medication from Transformation Health. You are being connected with an independent licensed provider who may prescribe medication if clinically appropriate, which is then prepared and delivered by a licensed pharmacy.

What Happens After You’re Approved

Once your provider approves a prescription:

Week 1:

• Your medication arrives with clear dosing instructions
• Your care team provides a patient guide covering what to expect, how to administer your medication, and side effect management
• You take your first dose at the recommended time
• 24/7 messaging support is available

Weeks 2-12 (Titration period):

• You increase your dose gradually on a schedule provided by your provider
• Regular check-ins with your provider or care team monitor how you’re tolerating the medication
• Lab work is ordered as part of your care plan and results are reviewed
• Nutrition guidance and fitness recommendations are tailored to your progress
• You have access to your care team if side effects develop or questions arise

Month 3 and beyond:

• You reach your target dose (or the dose that works best for you)
• Ongoing check-ins continue to monitor your progress
• You receive coaching focused on building sustainable eating and exercise habits
• Your provider evaluates whether any dose adjustments are needed
• Lab work is repeated as clinically indicated

Your monthly all-inclusive fee covers all of this: medication, provider care, lab work, nutrition coaching, fitness guidance, and shipping. There are no surprise bills or hidden fees at any point.

Eligibility Summary

Not all patients meeting BMI criteria will qualify. Your provider evaluates your complete health profile independently. If you have questions about whether you might qualify, the assessment itself provides that information.

Choosing Your Medication

If your provider determines GLP-1 is appropriate for you, your next decision is which medication and formulation. Your provider will make a final recommendation based on your health profile, but you can indicate your preference during the assessment.

Semaglutide (injectable), $249/month The most studied GLP-1 medication. Clinical trials have shown consistent weight loss results ^[6]. Well-suited for first-time GLP-1 users.

Semaglutide (oral), $279/month Same active ingredient and mechanism as injectable semaglutide. Taken as a daily tablet. Slightly lower cost than tirzepatide but higher than injectable semaglutide.

Tirzepatide (injectable or oral), $339/month A dual-acting medication that affects both GLP-1 and GIP receptors. Clinical trials show tirzepatide produces approximately 20% weight reduction in patients, with some studies showing results exceeding semaglutide ^[7]. Best for patients who may benefit from a dual-action approach.

Microdose program, $199/month Designed for patients already on GLP-1 who want to maintain results at a lower dose, or for patients with lower BMI (20+) starting medication for the first time.

For detailed information, visit our medication comparison page.

Frequently Asked Questions

Will my insurance cover this? Transformation Health is a direct-to-consumer service. We do not bill insurance. However, many insurance plans cover GLP-1 medications if prescribed by a provider in-network. You’re responsible for determining your coverage. We accept FSA and HSA cards, which many people use to pay for their medication.

What if I have a contraindication? If you have a condition that makes GLP-1 inappropriate, your provider will decline the prescription. You won’t be charged for the assessment. Your provider may discuss alternative approaches based on your health situation.

What are the side effects? The most common side effects are nausea, vomiting, and changes in appetite (which is the intended effect). Some patients experience constipation or changes in taste. Side effects are typically mild and decrease over time as your body adjusts. Your care team will provide detailed information and support for managing side effects. ^[6][7]

How long do I stay on the medication? That’s a decision you and your provider make together. GLP-1 medications are not intended to be permanent. The goal is to use the medication as a bridge while you build sustainable eating and exercise habits. Some patients reduce or stop medication after 6-12 months. Others maintain a lower dose longer-term. This is an ongoing conversation with your provider.

Will I regain the weight if I stop? Weight can return if you revert to previous eating patterns. The benefit of GLP-1 is that it gives you time and mental space to build different habits. If those habits stick, the weight often stays off even after you stop medication. This is not guaranteed. Individual results vary significantly.

Information About Compounded Medications

Compounded medications are prepared by state-licensed pharmacies and are not FDA-approved products. According to the FDA ^[4]:

“Compounded drugs are not reviewed by the FDA for safety, efficacy, or quality. Compounded drugs are not the same as FDA-approved generic drugs.”

The active ingredients in our products are studied compounds found in FDA-approved branded medications. However, compounded formulations may differ in purity, potency, or stability compared to branded products.

Your provider will discuss the benefits and limitations of compounded vs. branded GLP-1 medications with you. If you have concerns or prefer a branded product, discuss this with your provider.

Citations

[1] National Institutes of Health (NIDDK). “Prescription Medications to Treat Overweight & Obesity.” https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity

[2] National Institutes of Health (NIDDK). “Treatment for Overweight & Obesity.” https://www.niddk.nih.gov/health-information/weight-management/adult-overweight-obesity/treatment

[3] CDC National Center for Health Statistics. “Obesity and Severe Obesity Prevalence.” NCHS Data Brief 508. https://www.cdc.gov/nchs/products/databriefs/db508.htm

[4] FDA. “Compounding and the FDA: Q&A.” https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

[5] FDA. “FDA Approves New Medication for Chronic Weight Management” (Zepbound). https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management

[6] Wilding JPH, et al. “Weight regain and cardiometabolic effects after withdrawal of semaglutide.” (STEP 1 trial) NEJM 2021. https://pubmed.ncbi.nlm.nih.gov/33567185/

[7] Jastreboff AM, et al. “Tirzepatide once weekly for the treatment of obesity.” (SURMOUNT-1 trial) NEJM 2022. https://pubmed.ncbi.nlm.nih.gov/35658024/